Category: Vaccines

NIH and FDA Examine Serious Side Effect That Surfaced in COVID Vaccine Trial

Regulators in the United Kingdom allowed the AstraZeneca vaccine trial to resume, but U.S. regulators continue to investigate.

KHN’s ‘What the Health?’: The Politics of Science

Republicans have all but abandoned the Affordable Care Act as a campaign cudgel, judging from their national convention, at least. Meanwhile, career scientists at the federal government’s preeminent health agencies — the Food and Drug Administration, the Centers for Disease Control and Prevention and the National Institutes of Health — are all coming under increasing political pressure as the pandemic drags on. Joanne Kenen of Politico, Mary Ellen McIntire of CQ Roll Call and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss this and more. Plus, Rovner interviews KHN’s Elizabeth Lawrence about the latest KHN-NPR “Bill of the Month” installment.

Most Adults Wary of Taking Any Vaccine Approved Before the Election

About 60% of poll respondents are worried that federal regulators will rush to allow a vaccine because of political pressure. Opposition to getting a vaccine that might be authorized before the November election is strongest among Republicans.

With Schools Starting Online, Vaccinations Head for Recess

Traditionally, requirements that kids undergo certain immunizations before attending school have been a critical public health tool. Health officials are scrambling to make sure children don’t fall through the cracks.

As Threat of Valley Fever Grows Beyond the Southwest, Push Is On for Vaccine

Efforts are underway to bring to market a vaccine for valley fever, a fungal infection with COVID-like symptoms that occurs in the deserts of the Southwest. The illness is getting more attention as cases rise and a warming climate threatens to spread it through the West.

Health Officials Worry Nation’s Not Ready for COVID-19 Vaccine

As the nation awaits a vaccine to end the pandemic, local health departments say they lack the staff, money, tools ― and a unified plan ― to distribute, administer and track millions of vaccines, most of which will require two doses. Dozens of doctors, nurses and health officials interviewed by KHN and The Associated Press expressed their concern and frustration over federal shortcomings.

Dr. Fauci Says COVID Vaccine Trials Could End Early If Results Are Overwhelming

The nation’s top infectious disease official is confident that an independent panel will base vaccine approval on science, not politics.

Republican Convention, Day 4: Fireworks … and Shining a Light on Trump’s Claims

Donald Trump accepted his party’s nomination to seek reelection for a second term as president in front of a partisan audience that appeared to largely lack masks and opt against social distancing.

COVID + Influenza: This Is a Good Year to Get a Flu Shot, Experts Advise

A robust sign-up for flu shots could help head off a nightmare scenario in the coming winter of hospitals stuffed with both COVID-19 patients and those suffering from severe effects of influenza. Plus, no one knows how flu and COVID might interact if a patient got both.

LA Hospital Seeks Vaccine Trial Participants Among Its Own High-Risk Patients

Harbor-UCLA Medical Center serves patients who are especially vulnerable to the coronavirus: They are essential workers, have chronic diseases and are members of underrepresented racial and ethnic groups. When the safety-net hospital kicks off enrollment for its COVID-19 vaccine trial Wednesday, it will look to those patients to participate.